Immunology and Biologics

Safety Overview Looking at Differences and Similarities between Biologics

Safety Overview Looking at Differences and Similarities between Biologics

Dr. Ruderman will discuss safety issues with biological therapies…

Expiration Date: 8/12/2015

Max Credits: 0

View Activity

Biomarkers (RF, CCP, and 14-3-3η)

Biomarkers (RF, CCP, and 14-3-3η)

Dr. Maksymowych will discuss how to understand the role of a novel mediato…

Expiration Date: 7/20/2015

Max Credits: 0

View Activity

Immunogenicity and Drug Levels and their role in monitoring treatment

Immunogenicity and Drug Levels and their role in monitoring treatment

Dr. Kavanaugh discusses how to assess the role of immunogenicity in rheuma…

Expiration Date: 7/17/2015

Max Credits: 0

View Activity

IL-17: A Target for Therapy in RA

IL-17: A Target for Therapy in RA

Interleukin 17 (IL-17), a cytokine mainly produced by T cells, was definit…

Expiration Date: 6/30/2015

Max Credits: 0

View Activity

Kinase Inhibitors: Current and Potential

Kinase Inhibitors: Current and Potential

Dr. Markenson discusses the role of protein kinases in signal transduction…

Expiration Date: 8/14/2015

Max Credits: 0

View Activity

TB Screening and Monitoring in the Setting of RA

TB Screening and Monitoring in the Setting of RA

Dr. Winthrop discusses how to compare the benefits and drawbacks of differ…

Expiration Date: 7/16/2015

Max Credits: 0

View Activity

Immunizations (flu, pneumococcal) in RA patients on biologics and other agents

Immunizations (flu, pneumococcal) in RA patients on biologics and other agents

Dr. Calabrese discusses how to navigate the adult immunization schedule fr…

Expiration Date: 6/23/2015

Max Credits: 0

View Activity

Advancing Science: Incorporating New Options in Systemic Juvenile Idiopathic Arthritis Treatment

Advancing Science: Incorporating New Options in Systemic Juvenile Idiopathic Arthritis Treatment

Systemic juvenile idiopathic arthritis (JIA) accounts for 5% to 15% of pat…

Expiration Date: 6/11/2015

Max Credits: 0

View Activity

Reducing Complications in Systemic Juvenile Idiopathic Arthritis

Reducing Complications in Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis (JIA) accounts for 5% to 15% of pat…

Expiration Date: 6/11/2015

Max Credits: 0

View Activity

A Pan-European Registries Analysis of Abatacept Drug Retention in Rheumatoid Arthritis Patients with Inadequate Response to Prior Biologic Agents

A Pan-European Registries Analysis of Abatacept Drug Retention in Rheumatoid Arthritis Patients with Inadequate Response to Prior Biologic Agents

One of the projects that I'm presenting here at ACR is about Pan-European …

Expiration Date: 5/20/2015

Max Credits: 0

View Activity